. 2022 Mar 25;22(2):117–128. doi: 10.17245/jdapm.2022.22.2.117

Table 4. Comparison of changes in vital signs and average blood SpO₂ and EtCO₂ levels between fentanyl and remifentanil groups.

Patient indicators	Groups	Mean ± SD	t score	P
SBP change	Fentanyl	8.83 ± 8.25	-0.909	.366
SBP change	Remifentanil	11.4 ± 12.65	-0.909	.366
DBP change	Fentanyl	10.75 ± 9.71	1.996	.049^*
DBP change	Remifentanil	7.51 ± 4.77	1.996	.049^*
HR change	Fentanyl	9.94 ± 7.39	0.181	.857
HR change	Remifentanil	9.64 ± 7.80	0.181	.857
Respiratory rate changes per minute	Fentanyl	6.75 ± 11.20	2.179	.032^*
Respiratory rate changes per minute	Remifentanil	2.87 ± 4.26	2.179	.032^*
Minimum SpO₂ (%)	Fentanyl	95.03 ± 2.75	0.383	.705
Minimum SpO₂ (%)	Remifentanil	95.28 ± 3.11	0.383	.705
Average EtCO₂ (mmHg)	Fentanyl	33.59 ± 5.05	-2.077	.041^*
Average EtCO₂ (mmHg)	Remifentanil	38.09 ± 9.76	-2.077	.041^*

^*P < .05

DBP, diastolic blood pressure; EtCO₂, end-tidal carbon dioxide; HR, heart rate; SBP, systolic blood pressure; SD, standard deviation; SpO₂, peripheral capillary oxygen saturation.

Table 4. Comparison of changes in vital signs and average blood SpO2 and EtCO2 levels between fentanyl and remifentanil groups.

Table 4. Comparison of changes in vital signs and average blood SpO₂ and EtCO₂ levels between fentanyl and remifentanil groups.